Moleculin Stock Price on June 16, 2022 Breakdown

MBRX
 Stock
  

USD 1.73  0.03  1.76%   

As of today, the current price of Moleculin Biotech is  1.73 , as last reported on the 9th of August, with the highest price reaching  1.78  and the lowest price hitting  1.67  during the day.
Moleculin Biotech appears to be slightly risky, given 3 months investment horizon. Moleculin Biotech has Sharpe Ratio of 0.17, which conveys that the firm had 0.17% of return per unit of risk over the last 3 months. Our standpoint towards estimating the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By analyzing Moleculin Biotech technical indicators you can presently evaluate if the expected return of 0.64% is justified by implied risk. Please exercise Moleculin Biotech's Mean Deviation of 2.94, downside deviation of 4.23, and Risk Adjusted Performance of 0.0866 to check out if our risk estimates are consistent with your expectations.
  
Net Income Common Stock is likely to drop to about (16.3 M) in 2022. Moleculin Biotech Price to Book Value is fairly stable at the moment as compared to the past year. Moleculin Biotech reported Price to Book Value of 0.67 in 2021. Price to Sales Ratio is likely to rise to 5.88 in 2022, whereas Price to Earnings Ratio are likely to drop (3.40)  in 2022.

Moleculin Biotech Main Headline on 16th of June 2022

Financial Statements
by SEC
Financial Statements and Exhibits. Regulation FD Disclosure

Moleculin Biotech Valuation on June 16, 2022

It is possible to determine the worth of Moleculin Biotech on a given historical date. On June 16, 2022 Moleculin was worth 1.36 at the beginning of the trading date compared to the closed value of 1.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Moleculin Biotech stock. Still, in general, we apply an absolute valuation method to find Moleculin Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Moleculin Biotech's related companies.
 Open High Low Close Volume
  1.37    1.43    1.35    1.39    26,757  
06/16/2022
  1.36    1.39    1.26    1.33    51,731  
  1.31    1.49    1.31    1.49    67,975  
Backtest Moleculin Biotech  |  Moleculin Biotech History  |  Moleculin Biotech Valuation   PreviousNext  
Open Value 1.36
0.0133
Downside
1.33
Closing Value
12.76
Upside

Moleculin Biotech Trading Date Momentum on June 16, 2022

On June 17 2022 Moleculin Biotech CS was traded for  1.49  at the closing time. The top price for the day was 1.49  and the lowest listed price was  1.31 . The trading volume for the day was 68 K. The trading history from June 17, 2022 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 12.03% . The trading delta at closing time against the current closing price is 12.78% .

Moleculin Biotech Fundamentals Correlations and Trends

By evaluating Moleculin Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Moleculin Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Moleculin financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Moleculin Biotech Stock history

Moleculin Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moleculin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moleculin Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moleculin Biotech historical stock prices may prove useful in developing a viable investing in Moleculin Biotech
Last ReportedProjected for 2022
Weighted Average Shares26.9 M29 M
Weighted Average Shares Diluted26.9 M29 M
Issuance Purchase of Equity Shares74.7 M80.6 M
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Moleculin Biotech, Inc. was incorporated in 2015 and is headquartered in Houston, Texas. Moleculin Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Moleculin Biotech Quarterly Market Capitalization

50.87 Million

Moleculin Biotech Stock Technical Analysis

Moleculin Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Moleculin Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Moleculin Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Moleculin Biotech Period Price Range

Low
June 16, 2022
High

 1.36 

  

 1.33 

-0.03-2.21%

Moleculin Biotech August 9, 2022 Market Strength

Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech CS entry and exit signals to maximize returns

Moleculin Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Moleculin stock's direction in advance. Along with the technical and fundamental analysis of Moleculin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moleculin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Additionally, see Stocks Correlation. Note that the Moleculin Biotech information on this page should be used as a complementary analysis to other Moleculin Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Moleculin Stock analysis

When running Moleculin Biotech price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Moleculin Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moleculin Biotech. If investors know Moleculin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moleculin Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Moleculin Biotech is measured differently than its book value, which is the value of Moleculin that is recorded on the company's balance sheet. Investors also form their own opinion of Moleculin Biotech's value that differs from its market value or its book value, called intrinsic value, which is Moleculin Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moleculin Biotech's market value can be influenced by many factors that don't directly affect Moleculin Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moleculin Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Moleculin Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moleculin Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.